NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018

Shaji Kumar(Mayo Clinic), Dorothy A. Shead(University of the Witwatersrand), Yubin Kang(Duke University), Leona Holmberg, Jason C. Chandler(West Cancer Center), James Omel(Island Institute), Kelly Godby(University of Alabama at Birmingham), Craig C. Hofmeister(The Ohio State University), Vishala T. Neppalli(UC San Diego Health System), George Somlo(City Of Hope National Medical Center), Djordje Atanackovic(University of Maryland, Baltimore), Seema Singhal(All India Institute of Medical Sciences), Natalie S. Callander(University of Wisconsin–Madison), Matthew Faiman, Adetola A. Kassim(Vanderbilt University), Noopur Raje(Massachusetts General Hospital), Rashmi Kumar(University of London), Ehsan Malek(Roswell Park Comprehensive Cancer Center), Michaela Liedtke(Cancer Institute (WIA)), Melissa Alsina(Moffitt Cancer Center), Caitlin Costello(University of California San Diego), Carol Ann Huff(Sidney Kimmel Comprehensive Cancer Center), Keith Stockerl‐Goldstein(City Of Hope National Medical Center), Jorge Castillo(Dana-Farber Brigham Cancer Center), J. Sybil Biermann(American Society of Clinical Oncology), Henry C. Fung(Fox Chase Cancer Center), Donna Weber(The University of Texas MD Anderson Cancer Center), Sarah A. Holstein(University of Nebraska Medical Center), Thomas G. Martin(University of Colorado Boulder), Joachim Yahalom(Unknown)
Journal of the National Comprehensive Cancer Network
January 1, 2018
Cited by 203


Related Papers